Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anidulafungin PK for Antifungal Prophylaxis in HSCT and AML-MDS
NCT01249820Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Nov 2010
- Primary completion
- Jan 2013
- Modality
- Small Molecules, Cyclic Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of anidulafungin in invasive fungal disease (IFD), sponsored by Radboud University Medical Center. Started Nov 2010; status: completed.
02
Drugs
anidulafungin
03
Conditions
invasive fungal disease (IFD)
Beyond the preview
Go deeper on NCT01249820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01249820.